Experts worry insulin getting too expensive for many in U.S. and worldwide

Eric Palmer Healthcare professionals are concerned that hormone insulin meds, often the key diabetes treatment, are getting too costly for many patients, even in the U.S. In developing ...

A look at pharma’s many TV spokes-creatures

Damian Garde Over the past decade, pharma companies have increasingly relied on animated characters to advertise their products, using cute, quaint or questionable creatures to illustrate ...

Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1

Eric Palmer The first half of the year has provided a good ride for Big Pharma and its investors with indices up in the U.S. and Europe. Even Japanese drugmakers avoided the side effects ...

Novartis slashing thousands more jobs in global reorganization, shifting many to India

Tracy Staton Novartis' 500 Swiss job cuts announced earlier this month are just the tip of a global iceberg. The company plans to cut or shuffle up to 4,000 jobs in its pharma business, ...

ADHD experts worry that pharma ads drive too many kids to meds

Tracy Staton Is the huge rise in attention-deficit hyperactivity disorder diagnoses a pharma coup or public-health boon? FiercePharma News

Fighting Cancer May Be Harder As Many Drug Trials Are Undisclosedhed

esilverman To disclose or not to disclose? Shakespearean allusions aside, there is little question that drugmakers and researchers are under increasing pressure to comply with ...

China Arrested How Many Glaxo Employees? At Least 30, So Far…

esilverman The bribery and tax-evasion scandal unfolding in China has enveloped at least 30 GlaxoSmithKline employees, including as many as six executives who are under house ...

Vivus clears one of many hurdles for new weight drug

Ryan McBride The FDA has agreed to take down one of the big hurdles hampering U.S. sales of Vivus' newly approved weight drug Qsymia, but plenty more remain. Vivus ($ VVUS) says ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS